Daewon Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 200.42 million compared to KRW 34.15 million a year ago. Net income was KRW 9,632.05 million compared to KRW 10,505.25 million a year ago.

Basic earnings per share from continuing operations was KRW 459 compared to KRW 495 a year ago. Diluted earnings per share from continuing operations was KRW 450 compared to KRW 483 a year ago. Basic earnings per share was KRW 459 compared to KRW 495 a year ago.

Diluted earnings per share was KRW 450 compared to KRW 483 a year ago.